Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by METLIFE INC to the U.S. Securities and Exchange Commission. The reporting period covers holdings as of March 31, 2026. The document details specific equity positions held by the company, focusing on exchange-traded funds (ETFs) with international exposure.
Key Financial Metrics and Holdings
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for MetLife Inc. Instead, it lists specific investment positions with the following values:
| Issuer | Title of Class | Shares/Principal Amount | Value (USD) | Voting Authority |
|---|---|---|---|---|
| iShares Europe ETF | Europe ETF | 640,974 | $9,498 | Sole |
| iShares Latin America ETF Trust | Latn Amer | 2,531,535 | $71,751 | Sole |
| iShares MSCI Chile ETF Inc | MSCI Chile | 3,414,519 | $86,457 | Sole |
| iShares MSCI Japan ETF Inc | MSCI Japan | 854,600 | $10,189 | Sole |
| iShares MSCI Pacific ex Japan ETF | MSCI Pac J | 451,042 | $8,545 | Sole |
| State Street SPDR S&P ETF Trust | Tr Unit | 4,443,096 | $6,878 | Sole |
Note: The total value of the listed positions is approximately $193,318. All positions are reported with "Sole" voting authority and "DFND" (Discretionary) management.
Material Changes
The filing text does not provide comparative data from the prior reporting period. Consequently, material changes in holdings, values, or voting authority cannot be determined from this document alone.
Guidance, Outlook, and Risks
This Form 13F is a regulatory disclosure of holdings and does not contain management commentary, financial guidance, outlook, or risk factors. The filing includes a standard disclaimer stating that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Scope of Data: Verify that this filing represents only a subset of MetLife's total investment portfolio, as Form 13F typically reports only specific equity securities.
- Valuation Anomalies: Confirm the share prices implied by the "Value" and "Shares" columns, as the values listed (e.g., $9,498 for 640,974 shares) suggest extremely low per-share prices or potential data formatting issues in the source text.
- Consolidated Financials: Consult MetLife's 10-K or 10-Q filings for actual revenue, profit, and liquidity metrics, as they are absent here.
- Reporting Date: Confirm the accuracy of the "2026 Mar 31" date, as this represents a future date relative to the current real-time context, which may indicate a projection or a data entry error in the source.